phosphatidylcholines has been researched along with oxymatrine in 2 studies
Studies (phosphatidylcholines) | Trials (phosphatidylcholines) | Recent Studies (post-2010) (phosphatidylcholines) | Studies (oxymatrine) | Trials (oxymatrine) | Recent Studies (post-2010) (oxymatrine) |
---|---|---|---|---|---|
32,204 | 443 | 5,593 | 412 | 16 | 270 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Deng, Y; Du, S | 1 |
Du, S; Jin, S; Liu, M; Yan, H | 1 |
2 other study(ies) available for phosphatidylcholines and oxymatrine
Article | Year |
---|---|
Studies on the encapsulation of oxymatrine into liposomes by ethanol injection and pH gradient method.
Topics: 1-Octanol; Alkaloids; Cholesterol; Drug Compounding; Ethanol; Liposomes; Phosphatidylcholines; Phosphatidylserines; Proton-Motive Force; Quinolizines; Solubility; Water | 2006 |
Effect of oxymatrine HSPC liposomes on improving bioavailability, liver target distribution and hepatoprotective activity of oxymatrine.
Topics: Alanine Transaminase; Alkaloids; Animals; Aspartate Aminotransferases; Biological Availability; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Drug Liberation; Kidney; Liposomes; Liver; Male; Matrines; Mice; Myocardium; Phosphatidylcholines; Protective Agents; Quinolizines; Spleen; Tissue Distribution | 2017 |